EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus

Alieh Farshbaf, Farnaz Mohajertehran, Seyed Hamid Aghaee-Bakhtiari, Hossein Ayatollahi, Katayoun Douzandeh, Atessa Pakfetrat, Nooshin Mohtasham iD

Clinical and Experimental Dental Research · 2024

DOI: 10.1002/cre2.877 ↗

At a glance

Journal article in Clinical and Experimental Dental Research, 2024. Written by Alieh Farshbaf and 6 co-authors. Institution: Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Major MEDLINE topics: Carcinoma, Squamous Cell, Mouth Neoplasms, Lichen Planus, Oral, MicroRNAs. Cited 13 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY 4.0). Funded by: Mashhad University of Medical Sciences.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objectives

Recent studies highlighted the role of miR expressed in saliva as reliable diagnostic and prognostic tools in the long‐term monitoring of cancer processes such as oral squamous carcinoma (OSCC). Based on a few previous studies, it seems the miR‐3928 can be considered a master regulator in carcinogenesis, and it can be therapeutically exploited. This is the first study that compared oral potentially malignant disorder (OLP) and malignant (OSCC) lesions for miR‐3928 expression. Materials and Methods In this cross‐sectional study, saliva samples from 30 healthy control individuals, 30 patients with erosive/atrophic oral lichen planus, and 31 patients with OSCC were collected. The evaluation of miR‐3928 expression by q‐PCR and its correlation with clinicopathological indices were analyzed by Shapiro−Wilk, Kruskal−Wallis, Pearson's χ 2 , and Mann−Whitney tests. The p ‐value less than .05 indicated statistically significant results.

Results

Based on nonparametric Kruskal−Wallis test results, there was a statistically significant difference between the ages of three study groups ( p < .05). This test demonstrated a statistically significant difference between the average of miR‐3928 expression in three study groups ( p < .05). The result of the χ 2 test showed a statistically significant difference in miR‐3928 expression between patients with OLP ( p = .01) and also patients with OSCC ( p < .0001) in comparison to the control group.

Conclusions

The salivary miR‐3928 can play a tumor suppressive role in the pathobiology of OSCC, and it is significantly downregulated in patients. According to the potential tumor suppressive role of miR‐3928 in the OSCC process, we can consider this microRNA as a biomarker for future early diagnosis, screening, and potential target therapy.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsLichen Planus, OralMicroRNAsHead and Neck NeoplasmsHumansSquamous Cell Carcinoma of Head and NeckCross-Sectional StudiesDown-RegulationBiomarkers

Author keywords

head and neck squamous cell carcinomamiR-3928oral canceroral squamous cell carcinoma

Substances

BiomarkersMicroRNAs

Authors and institutions

  • Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Oral and Maxillofacial Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Oral and Maxillofacial Pathology, School of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Bioinformatics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Hematology Department, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran.

ORCID profiles: Nooshin Mohtasham

Funding

  • Mashhad University of Medical Sciences

Cite

APA

Farshbaf, A., Mohajertehran, F., Aghaee-Bakhtiari, S. H., Ayatollahi, H., Douzandeh, K., Pakfetrat, A., & Mohtasham, N. (2024). Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus. Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.877

Vancouver

Farshbaf A, Mohajertehran F, Aghaee-Bakhtiari SH, Ayatollahi H, Douzandeh K, Pakfetrat A, et al. Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus. Clinical and Experimental Dental Research. 2024. doi:10.1002/cre2.877

BibTeX
@article{Farshbaf2024,
  author = {Farshbaf, Alieh and Mohajertehran, Farnaz and Aghaee-Bakhtiari, Seyed Hamid and Ayatollahi, Hossein and Douzandeh, Katayoun and Pakfetrat, Atessa and Mohtasham, Nooshin},
  title = {Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus},
  journal = {Clinical and Experimental Dental Research},
  year = {2024},
  doi = {10.1002/cre2.877}
}
Start for free →